Inhibitors of Mitogen-Activated Protein Kinases
Downregulate COX-2 Expression in Human Chondrocytes
Riina Nieminen,
Sari Leinonen,
Aleksi Lahti,
Katriina Vuolteenaho,
Ulla Jalonen,
Hannu Kankaanranta,
Mary B. Goldring,
Eeva Moilanen
Affiliations
Riina Nieminen
The Immunopharmacology Research Group, Medical School, University of Tampere, and Tampere University Hospital, Research Unit, Tampere 33014, Finland
Sari Leinonen
The Immunopharmacology Research Group, Medical School, University of Tampere, and Tampere University Hospital, Research Unit, Tampere 33014, Finland
Aleksi Lahti
The Immunopharmacology Research Group, Medical School, University of Tampere, and Tampere University Hospital, Research Unit, Tampere 33014, Finland
Katriina Vuolteenaho
The Immunopharmacology Research Group, Medical School, University of Tampere, and Tampere University Hospital, Research Unit, Tampere 33014, Finland
Ulla Jalonen
The Immunopharmacology Research Group, Medical School, University of Tampere, and Tampere University Hospital, Research Unit, Tampere 33014, Finland
Hannu Kankaanranta
The Immunopharmacology Research Group, Medical School, University of Tampere, and Tampere University Hospital, Research Unit, Tampere 33014, Finland
Mary B. Goldring
Rheumatology Division, Beth Israel Deaconess Medical Center and New England Baptist Bone & Joint Institute, Harvard Institutes of Medicine, Boston 02215, MA, USA
Eeva Moilanen
The Immunopharmacology Research Group, Medical School, University of Tampere, and Tampere University Hospital, Research Unit, Tampere 33014, Finland